{"slug":"ihc-assay","tag":"ihc-assay","variants":["ihc-assay"],"description":"No description yet","count":3,"kinds":{"drug":3},"related":[{"slug":"test","tag":"test","shared":3}],"records":[{"id":"ventana-confirm-er-pr","kind":"drug","name":"VENTANA CONFIRM anti-ER (SP1) and anti-PR (1E2) antibodies","route":"/drugs/ventana-confirm-er-pr/","status":"approved","tldr":"Ventana's ready-to-use rabbit antibodies for staining the oestrogen and progesterone receptors in breast cancer tissue, cleared by the FDA in 2011 and 2012."},{"id":"dako-er-pr-ihc","kind":"drug","name":"Agilent (Dako) ER and PR immunohistochemistry: ER/PR pharmDx, ER clone EP1, PR clones PgR 636 and PgR 1294","route":"/drugs/dako-er-pr-ihc/","status":"approved","tldr":"Dako's antibodies and kit for staining the oestrogen and progesterone receptors in breast cancer tissue, cleared by the FDA between 2002 and 2017; Dako is now part of Agilent."},{"id":"leica-er-pr-ihc","kind":"drug","name":"Leica Biosystems ER clone 6F11 and PR clone 16 antibodies (Novocastra, BOND)","route":"/drugs/leica-er-pr-ihc/","status":"approved","tldr":"Leica's antibodies for staining the oestrogen receptor (clone 6F11) and progesterone receptor (clone 16) in breast cancer tissue, including ready-to-use versions for its BOND stainers."}]}